Stock Events

Stock Events

SILO Pharma 

$2.45
23
-$0.05-2% Thursday 20:00
-$0.04-1.63%Thursday 23:47After hours

Statistics

Day High
2.45
Day Low
2.45
52W High
15.15
52W Low
2.37
Volume
-
Avg. Volume
-
Mkt Cap
4.3M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

2DecExpected
Q3 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-3.45
-2.34
-1.23
-0.12
Expected EPS
N/A
Actual EPS
N/A

Financials

-5,872.22%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
72,000Revenue
-4.23MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow SILO. It's not an investment recommendation.
Apple
3
AAPL
Microsoft
3
MSFT
NVIDIA
3
NVDA
Alphabet
3
GOOGL

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
AtaiBeckley
ATAI
Mkt Cap2.7B
ATAI Life Sciences is a biotech company focusing on psychedelic and non-psychedelic compounds for mental health, competing in the same space as SILO Pharma.
GH Research
GHRS
Mkt Cap1.92B
GH Research PLC is developing therapeutic solutions based on psychedelic substances, making it a competitor in the psychedelic-based treatment market alongside SILO Pharma.
Nuveen Municipal Income
NUMI
Mkt Cap0
Numinus Wellness Inc. focuses on psychedelic therapy development, including support services, competing with SILO Pharma in the broader psychedelic healthcare sector.
Revive Therapeutics
RVVTF
Mkt Cap9.15M
Revive Therapeutics Ltd. explores the use of psychedelics for medical conditions, directly competing with SILO Pharma's therapeutic development efforts.
Noveris Health Sciences
MYCOF
Mkt Cap64.4M
Mydecine Innovations Group Inc. is working on developing and commercializing psychedelic medicines, making it a competitor in the psychedelic pharmaceuticals market.

About

SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's portfolio includes programs such as SPC-15 for PTSD, SP-26 for fibromyalgia and chronic pain, and preclinical assets targeting Alzheimer's disease and multiple sclerosis. The company's product pipelines include: SPC-14, SPC-15, SP-26, and SPU-16. The company operates as a single operating segment as a clinical-stage biopharmaceutical company focused on developing new generation therapies for unmet medical need.
Show more...
CEO
Eric Weisblum
Employees
3
Country
United States
ISIN
US82711P3001

Listings

XNAS
US
SILO
BOATS
BOATS
SILO.BOATS

0 Comments

Share your thoughts

FAQ

What is SILO Pharma stock price today?▼
The current price of SILO is $2.45 USD — it has decreased by -2% in the past 24 hours. Watch SILO Pharma stock price performance more closely on the chart.
What is SILO Pharma stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange SILO Pharma stocks are traded under the ticker SILO.
Is SILO Pharma stock price growing?▼
SILO stock has fallen by -3.54% compared to the previous week, the month change is a -46.74% fall, over the last year SILO Pharma has showed a -72.81% decrease.
What is SILO Pharma market cap?▼
Today SILO Pharma has the market capitalization of 4.3M
When is the next SILO Pharma earnings date?▼
SILO Pharma is going to release the next earnings report on December 02, 2026.
What is SILO Pharma revenue for the last year?▼
SILO Pharma revenue for the last year amounts to 72,000 USD.
What is SILO Pharma net income for the last year?▼
SILO net income for the last year is -4.23M USD.
How many employees does SILO Pharma have?▼
As of September 04, 2026, the company has 3 employees.
In which sector is SILO Pharma located?▼
SILO Pharma operates in the Health & Wellness sector.
When did SILO Pharma complete a stock split?▼
The last stock split for SILO Pharma was on June 03, 2026 with a ratio of 1:15.
Where is SILO Pharma headquartered?▼
SILO Pharma is headquartered in SARASOTA, United States.